Isomorphic Labs, a drug discovery company founded by Demis Hassabis, has secured $5 billion in funding. The company, which is affiliated with Google/Deepmind, has not yet tested any drugs in human trials. This significant funding round highlights investor confidence in AI-driven approaches to pharmaceutical development. AI
IMPACT This substantial investment signals strong market belief in AI's potential to accelerate drug discovery and development.
RANK_REASON Significant funding round for an AI-focused drug discovery company. [lever_c_demoted from significant: ic=1 ai=0.7]
Read on Mastodon — mastodon.social →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →